STOCK TITAN

Tivic Health Systems Inc - TIVC STOCK NEWS

Welcome to our dedicated page for Tivic Health Systems news (Ticker: TIVC), a resource for investors and traders seeking the latest updates and insights on Tivic Health Systems stock.

Overview of Tivic Health Systems Inc

Tivic Health Systems Inc is a pioneering health technology company specializing in the development and commercialization of bioelectronic medicine solutions. By harnessing the potential of non-invasive therapy and microcurrent stimulation, the company offers innovative and natural alternatives to improve health outcomes. Its approach is deeply rooted in activating the body’s intrinsic healing mechanisms, thus providing a fresh perspective compared to conventional chemical-based treatments.

Innovative Product Focus: ClearUP Sinus Relief

At the heart of Tivic Health Systems Inc’s product lineup is ClearUP Sinus Relief. This first commercial product is a patented, handheld medical device that employs ultra-low current electrical waves to alleviate sinus pain, congestion, and pressure. The device is designed specifically to address recurring sinus ailments such as nasal allergies, sinus infections, and chronic sinusitis. It offers a natural method of relief without relying on pills, sprays, or traditional saline flushes, thereby appealing to those seeking non-pharmaceutical alternatives for sinus care.

Technology and Therapeutic Innovation

The company’s innovative platform is built on the application of microcurrents, which can be finely programmed to target various therapeutic outcomes. This technology aims to harness the body's own healing signals, establishing a foundation for a variety of applications beyond sinus care. The integration of programmable bioelectronic therapy into a portable device marks a significant leap in merging technology with holistic health approaches, ensuring treatments that are both efficient and minimally intrusive.

Business Model and Market Presence

Tivic Health Systems Inc operates within the expanding realm of health technology and medical devices. The company generates revenue through the sale and potential licensing of its proprietary devices, with a focus on delivering tangible health benefits without the dependency on synthetic chemicals. The market for non-invasive therapeutic devices is growing, driven by increasing consumer demand for natural, side-effect free treatments. Thus, Tivic Health Systems Inc is positioned in a competitive landscape where technological innovation meets the evolving needs of patients looking for safer, alternative therapeutic solutions.

Competitive Landscape and Differentiation

In the context of its industry, Tivic Health Systems Inc stands apart by challenging the conventional reliance on pharmaceuticals. Traditional treatments for sinus issues generally involve chemical sprays, medications, or procedural interventions. In contrast, Tivic Health’s approach with ClearUP Sinus Relief leverages physical stimulation via microcurrents to offer a non-pharmaceutical and non-invasive solution. This not only differentiates the company within the health technology sector but also appeals to a demographic seeking modern, technology-driven health remedies.

Industry Terminologies and Technical Insight

Within the framework of bioelectronic medicine, terms like 'microcurrent therapy' and 'non-invasive bioelectronic stimulation' are central to understanding the company’s value proposition. These methods focus on promoting the body’s innate repair processes using controlled electrical impulses, which can mitigate symptoms without the systemic side effects often encountered with oral medications or injections. This technical foundation demonstrates not only the innovative spirit of Tivic Health Systems Inc but also its commitment to advancing the field through research and application of cutting-edge medical technology.

Expert Analysis and Future Applications

The depth of Tivic Health Systems Inc’s approach is rooted in its commitment to research and technological advancement. While its current focus is on sinus pain relief, the underlying technology presents opportunities for applications in treating other conditions where the enhancement of the body’s natural healing capabilities could be beneficial. This positions the company as a key player in the broader narrative of evolving medical technologies that prioritize user-friendly, risk-averse treatment modalities.

Conclusion

In summary, Tivic Health Systems Inc is at the forefront of a transformative approach in bioelectronic medicine. With a clear emphasis on non-invasive, technology-driven therapeutic solutions, the company is redefining the way sinus pain and potentially other conditions are managed. By integrating scientific rigor with innovative design, Tivic Health Systems Inc provides a comprehensive alternative to established medical treatments, catering to patients and healthcare professionals who value precision, efficiency, and low-risk intervention options.

Rhea-AI Summary
Tivic Health® Systems, Inc. has received study approval for its bioelectronic device approach to vagus nerve stimulation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
81.08%
Tags
none
-
Rhea-AI Summary
Tivic Health announced Q2 2023 financial results. Gross profit increased to 37.5% from 23.4% in Q2 2022. Net loss decreased to $2.1 million from $3.0 million. Cash and cash equivalents totaled $2.7 million. Operating expenses reduced to $2.2 million from $3.1 million. Signed distribution agreement with Cardinal Health. Sold shares of common stock for $5.2 million. Shareholders voted for reverse stock split. Q2 revenue decreased by 70% to $161 thousand. Marketing expense reductions led to 82% decline in unit sales offset by 69% increase in average price per unit.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.5%
Tags
-
Rhea-AI Summary
Tivic Health Systems, Inc. (Nasdaq: TIVC) will report financial results for Q1 2023 on August 14th, 2023. The conference call and webcast will be pre-recorded and start at 1:30 pm PT / 4:30 pm ET. Shareholders can submit questions in advance until August 8th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.89%
Tags
Rhea-AI Summary
Tivic Health Systems, Inc. has announced the pricing of its public offering of 33,173,000 shares of common stock at a price of $0.041 per share. The gross proceeds from the offering are expected to be approximately $1.4 million. The net proceeds will be used for working capital and general corporate purposes. The offering is being facilitated by Maxim Group LLC as the sole placement agent.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.5%
Tags
-
Rhea-AI Summary
Tivic Health Systems, a health tech company, plans to offer and sell shares of its common stock in a public offering. The net proceeds will be used for working capital and general corporate purposes. The offering is subject to market conditions and there is no assurance on its completion or terms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.5%
Tags
-
Rhea-AI Summary
Tivic Health Systems, Inc. has received its sixth patent for its bioelectronic platform, expanding its intellectual property. The patent includes proprietary contacts, conductive circuitry design, and algorithms to optimize therapy delivery. The company has an additional 17 patents pending. Tivic's first commercial product, ClearUP, is an FDA-approved over-the-counter bioelectronic device for treating inflammation symptoms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2%
Tags
none
-
Rhea-AI Summary
Tivic Health Systems, Inc. (Nasdaq: TIVC) has announced the pricing of its public offering of 51,250,000 shares of common stock at a price of $0.04 per share. The gross proceeds are expected to be approximately $2.1 million. The net proceeds will be used for working capital and general corporate purposes. The offering is being facilitated by Maxim Group LLC as the sole placement agent.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-28.57%
Tags
-
Rhea-AI Summary
Tivic Health Systems, a health tech company, plans to offer and sell shares of its common stock in a public offering. The net proceeds will be used for working capital and general corporate purposes. The completion of the offering is subject to market conditions. Maxim Group LLC is the sole placement agent for the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-28.57%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.23%
Tags
none

FAQ

What is the current stock price of Tivic Health Systems (TIVC)?

The current stock price of Tivic Health Systems (TIVC) is $6.91 as of April 23, 2025.

What is the market cap of Tivic Health Systems (TIVC)?

The market cap of Tivic Health Systems (TIVC) is approximately 2.3M.

What is the core focus of Tivic Health Systems Inc?

Tivic Health Systems Inc specializes in developing non-invasive bioelectronic medicine solutions. Its main focus is on using microcurrent technology to stimulate the body’s healing mechanisms, offering natural alternatives to traditional pharmaceutical treatments.

How does ClearUP Sinus Relief work?

ClearUP Sinus Relief uses ultra-low current electrical waves to alleviate sinus pain and congestion. The device is designed to address symptoms of nasal allergies, sinus infections, and other related conditions without relying on conventional chemical-based treatments.

What distinguishes Tivic Health Systems Inc from traditional pharmaceutical approaches?

Unlike traditional pharmaceuticals that use synthetic chemicals, Tivic Health Systems Inc employs bioelectronic stimulation to activate the body’s own healing responses. This technology-driven approach provides a natural and non-invasive alternative for managing pain and congestion.

Who can benefit from Tivic Health Systems Inc's products?

Individuals suffering from recurring sinus issues such as congestion, pain, and pressure can benefit from Tivic Health Systems Inc's solutions. The company’s non-invasive therapies offer an alternative for those looking for relief without the usual side effects associated with pills or sprays.

What is bioelectronic medicine?

Bioelectronic medicine is an emerging field that utilizes electronic devices to regulate the body’s natural systems for therapeutic purposes. It focuses on using controlled electrical impulses to activate healing mechanisms, offering a novel approach compared to traditional drug therapies.

How does Tivic Health Systems Inc ensure the safety and quality of its products?

The company integrates rigorous research and testing protocols into its product development process. This commitment to quality ensures the devices not only meet safety standards but also effectively deliver the intended therapeutic benefits without invasive procedures.
Tivic Health Systems Inc

Nasdaq:TIVC

TIVC Rankings

TIVC Stock Data

2.34M
618.92k
0.13%
2.57%
5.29%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
FREMONT